高级检索
当前位置: 首页 > 详情页

Chronic HBV Carrier's acceptance of regular surveilling program in China

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Devivis Clin Immunol,Wuhan 430030,Peoples R China [2]China Three Gorges Univ, Coll Clin Med Sci 1, Dept Infect Dis, Yichang 443003, Peoples R China [3]Yichang Cent Peoples Hosp, Yichang 443003, Peoples R China [4]Huazhong Univ Sci & Technol, Union Hosp, Dept Infect Dis, Tongji Med Coll, Wuhan 430022, Peoples R China
出处:
ISSN:

关键词: hepatitis B virus compliance follow-up outpatient

摘要:
Long-term compliance with regular surveillance is important for the prevention and timely management of chronic hepatitis B (CHB). However, there are no researches focusing on the compliance of hepatitis B virus infected patients in regular surveillance so far. The purpose of our study was to investigate the outpatient compliance with long-term regular surveillance in China. Data of 3257 CHB outpatients was pooled and analyzed to assess the outpatient's compliance with the long-term regular surveillance plan. In all outpatients, the non-follow-up and the follow-up group accounted for 73.2% and 26.8%, respectively. Among the follow-up outpatient's, only 48.9% received ongoing-follow-up and 51.1% were finally lost to follow-up; the median length of visiting duration was 25 months; and the predictive 1-, 2-, 3-, 4- and 5-year ongoing follow-up rate was 72.7%, 52.5%, 42.4%, 33.8%, and 26.3%, respectively. In conclusion, our survey proved that the regular long-term surveillance on Chinese chronic HBV carrier is difficult to be fully implemented. A large proportion of outpatients do not receive routine follow-up and are at risk of treatment delay due to various social reasons.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 4 区 医学
小类 | 4 区 生化与分子生物学
最新[2025]版:
JCR分区:
出版当年[2011]版:
Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2024]版:

影响因子: 最新[2024版] 最新五年平均 出版当年[2011版] 出版当年五年平均 出版前一年[2010版] 出版后一年[2012版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Devivis Clin Immunol,Wuhan 430030,Peoples R China [2]China Three Gorges Univ, Coll Clin Med Sci 1, Dept Infect Dis, Yichang 443003, Peoples R China [3]Yichang Cent Peoples Hosp, Yichang 443003, Peoples R China
通讯作者:
通讯机构: [1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Devivis Clin Immunol,Wuhan 430030,Peoples R China [4]Huazhong Univ Sci & Technol, Union Hosp, Dept Infect Dis, Tongji Med Coll, Wuhan 430022, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:811 今日访问量:0 总访问量:560 更新日期:2025-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)